0.307 USD
-0.01 (-1.98%)
At close: Jan 30, 2026
0.3075 USD
+0 (+0.16%)
After Hours: 1/30/2026, 8:00:02 PM
ITRM gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. ITRM has a bad profitability rating. Also its financial health evaluation is rather negative. ITRM does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year ITRM has reported negative net income.
- In the past year ITRM has reported a negative cash flow from operations.
- ITRM had negative earnings in each of the past 5 years.
- ITRM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -82.95%, ITRM is not doing good in the industry: 75.92% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -82.95% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-89.08%
ROA(5y)-105.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for ITRM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for ITRM has been increased compared to 1 year ago.
- The number of shares outstanding for ITRM has been increased compared to 5 years ago.
- The debt/assets ratio for ITRM is higher compared to a year ago.
2.2 Solvency
- ITRM has an Altman-Z score of -23.38. This is a bad value and indicates that ITRM is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of ITRM (-23.38) is worse than 85.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -23.38 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 2.13 indicates that ITRM has no problem at all paying its short term obligations.
- ITRM's Current ratio of 2.13 is in line compared to the rest of the industry. ITRM outperforms 40.31% of its industry peers.
- A Quick Ratio of 1.96 indicates that ITRM should not have too much problems paying its short term obligations.
- The Quick ratio of ITRM (1.96) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.96 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 63.50% over the past year.
EPS 1Y (TTM)63.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- ITRM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.81% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y58.09%
EPS Next 2Y34.1%
EPS Next 3Y27.71%
EPS Next 5Y23.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- ITRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ITRM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as ITRM's earnings are expected to grow with 27.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.1%
EPS Next 3Y27.71%
5. Dividend
5.1 Amount
- No dividends for ITRM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ITERUM THERAPEUTICS PLC / ITRM FAQ
What is the ChartMill fundamental rating of ITERUM THERAPEUTICS PLC (ITRM) stock?
ChartMill assigns a fundamental rating of 1 / 10 to ITRM.
What is the valuation status for ITRM stock?
ChartMill assigns a valuation rating of 1 / 10 to ITERUM THERAPEUTICS PLC (ITRM). This can be considered as Overvalued.
What is the profitability of ITRM stock?
ITERUM THERAPEUTICS PLC (ITRM) has a profitability rating of 0 / 10.